Cyclooxygenase as a Target for the Antiamyloidogenic Activities of Nonsteroidal Anti-Inflammatory Drugs in Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1424-8638|11|5|293-297

ISSN： 1424-862x

Source： Neurosignals, Vol.11, Iss.5, 2003-01, pp. : 293-297

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-Steroidal Anti-Inflammatory Drugs in Alzheimer's Disease and Parkinson's Disease: Reconsidering the Role of Neuroinflammation

By Moore Amy H.   Bigbee Matthew J.   Boynton Grace E.   Wakeham Colin M.   Rosenheim Hilary M.   Staral Christopher J.   Morrissey James L.   Hund Amanda K.  

Pharmaceuticals, Vol. 3, Iss. 6, 2010-06 ,pp. : 1812-1841

MDPI

Access to resources Recommend Favorite

Anti-amyloidogenic therapies: strategies for prevention and treatment of Alzheimer’s disease

By Hamaguchi T.   Ono K.   Yamada M.  

Cellular and Molecular Life Sciences CMLS, Vol. 63, Iss. 13, 2006-07 ,pp. : 1538-1552

Springer Publishing Company

Access to resources Recommend Favorite

Nonsteroidal Anti-Inflammatory Drugs and the Kidney

By Hörl Walter H.  

Pharmaceuticals, Vol. 3, Iss. 7, 2010-07 ,pp. : 2291-2321

MDPI

Access to resources Recommend Favorite

Oxicams, a class of nonsteroidal anti‐inflammatory drugs and beyond

By  

IUBMB LIFE, Vol. 66, Iss. 12, 2014-12 ,pp. : 803-811

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hypersensitivity Reactions to Nonsteroidal Anti-Inflammatory Drugs: An Update

By Sánchez-Borges Mario   Caballero-Fonseca Fernan   Capriles-Hulett Arnaldo   González-Aveledo Luis  

Pharmaceuticals, Vol. 3, Iss. 1, 2010-01 ,pp. : 10-18

MDPI

Access to resources Recommend Favorite